Immune therapy of metastatic melanoma developing after allogeneic bone marrow transplant

Metastatic melanoma is frequently treated with immune activating therapy, which poses a theoretical risk of inducing graft versus host disease (GVHD) in those who have received allogeneic stem cell transplantation. The literature reporting the safety of immunotherapy in post transplant patients is l...

Descripción completa

Detalles Bibliográficos
Autores principales: Cecchini, Michael, Sznol, Mario, Seropian, Stuart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372324/
https://www.ncbi.nlm.nih.gov/pubmed/25806109
http://dx.doi.org/10.1186/s40425-015-0054-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372324/
https://www.ncbi.nlm.nih.gov/pubmed/25806109
http://dx.doi.org/10.1186/s40425-015-0054-4

Ejemplares similares